Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
- - - - - - - 319K
0.84%0.88%36.85x5.33x6.97x23.77x29.06x 44.99B
1.42%1.52%17.09x1.66x1.91x9.04x11.73x 33.69B
0.74%0.61%24.09x3.96x4.21x15.66x19.03x 11.6B
0.91%1.03%26.58x2.95x3.26x16.71x21.29x 11.68B
3.53%3.71%19.23x3.19x3.32x12.1x14.64x 8.94B
5.63%5.67%8.19x1.43x1.92x5.04x6.1x 7.01B
0.25%0.27%32.55x5.76x3.7x15.73x17.36x 6.35B
3.66%3.52%14.66x1.28x1.93x7.29x9.76x 6.51B
1.08%1.3%36.67x8.43x7.01x25.99x29.02x 4.03B
1.38%1.77%15.45x0.72x1.95x8.23x11.2x 3.91B
4.12%5.3%12.86x2.16x2.17x10.22x10.6x 3.22B
2.87%3.19%20.88x5.62x6.56x18.63x20.16x 2.91B
2.77%2.85%14.35x2.88x3.32x12.41x13.71x 2.85B
Average 2.25% 2.43% 21.50x 3.49x 3.71x 13.91x 16.44x 10.55B
Weighted average by Cap. 1.63% 1.72% 25.09x 3.57x 4.17x 15.58x 19.04x
Generic Pharmaceuticals
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!